Home > Insider Trading > Filing (0001062993-17-000505)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875622	Biospecifics Technologies Corp	BSTC	Pharmaceutical Preparations (2834)	113054851

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1355189	Thomas Wegman	C/O Biospecifics Technologies Corp. 35 Wilbur Street Lynbrook NY 11563	President	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $.001 Par Value	Disposition	2016-11-28	11,055	$48.04	301,494	No	4	S	Direct
Common Stock, $.001 Par Value	Disposition	2016-11-29	8,945	$48.32	292,549	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The selling price of $48.0369 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $47.50 to $49.40. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The selling price of $48.3161 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $48.25 to $48.77. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The purpose of this Form 4/A is solely to correct the amount of securities beneficially owned by the reporting person and does not represent any acquisition or disposition of shares by the reporting person.